Page last updated: 2024-11-12
jaboticabin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
jaboticabin: depside from the fruit of jaboticaba (Myrciaria cauliflora); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 16083179 |
| CHEMBL ID | 495849 |
| SCHEMBL ID | 1772894 |
| MeSH ID | M0502025 |
Synonyms (5)
| Synonym |
|---|
| jaboticabin |
| CHEMBL495849 |
| SCHEMBL1772894 |
| 3,5-dihydroxy-2-(methoxycarbonylmethyl)phenyl 3,4-dihydroxybenzoate |
| [3,5-dihydroxy-2-(2-methoxy-2-oxoethyl)phenyl] 3,4-dihydroxybenzoate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID378422 | Inhibition of IL8 production in human SAE cells at 100 uM | 2006 | Journal of natural products, Aug, Volume: 69, Issue:8 | Bioactive depsides and anthocyanins from jaboticaba (Myrciaria cauliflora). |
| AID378424 | Cytotoxicity against human HT-29 cells after 72 hrs | 2006 | Journal of natural products, Aug, Volume: 69, Issue:8 | Bioactive depsides and anthocyanins from jaboticaba (Myrciaria cauliflora). |
| AID378421 | Antiradical activity assessed as DPPH radical scavenging activity | 2006 | Journal of natural products, Aug, Volume: 69, Issue:8 | Bioactive depsides and anthocyanins from jaboticaba (Myrciaria cauliflora). |
| AID378423 | Inhibition of IL8 production in cigarette smoke extract treated human SAE cells at 100 uM | 2006 | Journal of natural products, Aug, Volume: 69, Issue:8 | Bioactive depsides and anthocyanins from jaboticaba (Myrciaria cauliflora). |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 60.59
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (60.59) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||